Corient Private Wealth LP Buys New Stake in Heartflow, Inc. $HTFL

Corient Private Wealth LP bought a new stake in Heartflow, Inc. (NASDAQ:HTFL) in the 2nd quarter, HoldingsChannel reports. The fund bought 49,666 shares of the company’s stock, valued at approximately $1,457,000.

A number of other large investors have also made changes to their positions in the business. XXEC Inc. acquired a new stake in shares of Heartflow in the 2nd quarter worth $2,524,764,000. Quantinno Capital Management LP acquired a new position in Heartflow during the 1st quarter valued at about $1,734,000. Sei Investments Co. increased its position in Heartflow by 342.5% during the 1st quarter. Sei Investments Co. now owns 67,048 shares of the company’s stock valued at $1,631,000 after buying an additional 51,895 shares in the last quarter. Bank of New York Mellon Corp purchased a new stake in Heartflow in the second quarter valued at about $19,096,000. Finally, Handelsbanken Fonder AB acquired a new stake in Heartflow in the second quarter worth about $910,000.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. JPMorgan Chase & Co. upped their price objective on shares of Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a report on Friday, August 14th. Canaccord Genuity Group lifted their target price on shares of Heartflow from $37.00 to $45.00 and gave the stock a “buy” rating in a research note on Friday, August 14th. Weiss Ratings raised shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 7th. Piper Sandler restated an “overweight” rating and set a $45.00 price target (up from $38.00) on shares of Heartflow in a research note on Friday, August 14th. Finally, Benchmark reaffirmed a “buy” rating on shares of Heartflow in a report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Heartflow currently has an average rating of “Moderate Buy” and a consensus price target of $43.43.

Heartflow Stock Performance

Heartflow stock opened at $49.71 on Friday. The business’s 50-day simple moving average is $33.50 and its two-hundred day simple moving average is $29.79. The company has a market cap of $4.32 billion and a PE ratio of -27.16. Heartflow, Inc. has a fifty-two week low of $20.13 and a fifty-two week high of $51.78.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.15. The firm had revenue of $64.08 million during the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The business’s revenue for the quarter was up 47.7% compared to the same quarter last year. As a group, analysts predict that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Campbell Rogers sold 9,219 shares of the stock in a transaction on Monday, August 17th. The shares were sold at an average price of $41.23, for a total value of $380,099.37. Following the sale, the insider owned 86,459 shares in the company, valued at $3,564,704.57. This represents a 9.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John Farquhar sold 38,900 shares of the stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $35.00, for a total transaction of $1,361,500.00. Following the completion of the sale, the chief executive officer owned 457,935 shares in the company, valued at $16,027,725. The trade was a 7.83% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 191,271 shares of company stock valued at $7,089,136 over the last three months. 7.70% of the stock is currently owned by insiders.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.